Division of Endocrinology and Metabolism, Department of Medicine, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Cardiovasc Diabetol. 2019 Nov 16;18(1):157. doi: 10.1186/s12933-019-0953-7.
Both type 1 and type 2 diabetes are well-established risk factors for cardiovascular disease and early mortality. However, few studies have directly compared the hazards of cardiovascular outcomes and premature death among people with type 1 diabetes to those among people with type 2 diabetes and subjects without diabetes. Furthermore, information about the hazard of cardiovascular disease and early mortality among Asians with type 1 diabetes is sparse, although the clinical and epidemiological characteristics of Asians with type 1 diabetes are unlike those of Europeans. We estimated the hazard of myocardial infarction (MI), hospitalization for heart failure (HF), atrial fibrillation (AF), and mortality during follow-up in Korean adults with type 1 diabetes compared with those without diabetes and those with type 2 diabetes.
We used Korean National Health Insurance Service datasets of preventive health check-ups from 2009 to 2016 in this retrospective longitudinal study. The hazard ratios of MI, HF, AF, and mortality during follow-up were analyzed using the Cox regression analyses according to the presence and type of diabetes in ≥ 20-year-old individuals without baseline cardiovascular disease (N = 20,423,051). The presence and type of diabetes was determined based on the presence of type 1 or type 2 diabetes at baseline.
During more than 93,300,000 person-years of follow-up, there were 116,649 MIs, 135,532 AF cases, 125,997 hospitalizations for HF, and 344,516 deaths. The fully-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for incident MI, hospitalized HF, AF, and all-cause death within the mean follow-up of 4.6 years were higher in the type 1 diabetes group than the type 2 diabetes [HR (95% CI) 1.679 (1.490-1.893) for MI; 2.105 (1.901-2.330) for HF; 1.608 (1.411-1.833) for AF; 1.884 (1.762-2.013) for death] and non-diabetes groups [HR (95% CI) 2.411 (2.138-2.718) for MI; 3.024 (2.730-3.350) for HF; 1.748 (1.534-1.993) for AF; 2.874 (2.689-3.073) for death].
In Korea, the presence of diabetes was associated with a higher hazard of cardiovascular disease and all-cause death. Specifically, people with type 1 diabetes had a higher hazard of cardiovascular disease and all-cause mortality compared to people with type 2 diabetes.
1 型和 2 型糖尿病均是心血管疾病和早期死亡的既定危险因素。然而,鲜有研究直接比较 1 型糖尿病患者与 2 型糖尿病患者及无糖尿病患者的心血管结局和过早死亡风险。此外,亚洲 1 型糖尿病患者的心血管疾病和早期死亡率信息较为匮乏,尽管亚洲 1 型糖尿病患者的临床和流行病学特征与欧洲患者不同。我们评估了韩国成年人中 1 型糖尿病患者与无糖尿病患者和 2 型糖尿病患者相比,在随访期间心肌梗死(MI)、心力衰竭(HF)住院、心房颤动(AF)和死亡率的风险。
我们在这项回顾性纵向研究中使用了韩国国家健康保险服务 2009 年至 2016 年的预防健康检查数据集。根据基线时无心血管疾病(N=20,423,051)的个体是否存在及糖尿病类型,采用 Cox 回归分析评估随访期间 MI、HF、AF 和死亡率的风险比。基于糖尿病的存在与否,确定了糖尿病的存在和类型。
在超过 9330 万个人年的随访期间,发生了 116649 例 MI、135532 例 AF 病例、125997 例 HF 住院和 344516 例死亡。在平均随访 4.6 年期间,1 型糖尿病组与 2 型糖尿病[MI 的全调整危险比(HR)和 95%置信区间(CI)为 1.679(1.490-1.893);HF 为 2.105(1.901-2.330);AF 为 1.608(1.411-1.833);所有原因死亡为 1.884(1.762-2.013)]和无糖尿病组[MI 为 2.411(2.138-2.718);HF 为 3.024(2.730-3.350);AF 为 1.748(1.534-1.993);所有原因死亡为 2.874(2.689-3.073)]的新发 MI、HF 住院、AF 和全因死亡的 HR 更高。
在韩国,糖尿病的存在与心血管疾病和全因死亡风险的增加有关。具体而言,1 型糖尿病患者的心血管疾病和全因死亡率高于 2 型糖尿病患者。